Skip to main content

Latest stock market podcasts

From the helm: Proteomics International (ASX:PIQ), Dr. Richard Lipscombe, Managing Director

Bell Direct
July 7, 2025

In this episode of From the helm, Bell Financial Group’s Grady Wulff speaks with Proteomics International Laboratories (ASX: PIQ) CEO, Dr. Richard Lipscombe, about the company’s ground breaking work in predictive diagnostics and the global opportunity for its world-first blood tests.

In this video, Dr. Lipscombe covers:
·      (0:47): An overview of PIQ and its FY26 goals
·      (1:38): The significance of three world-first blood tests
·      (5:26): The global addressable markets for these conditions
·      (6:25): Clinical trial progress and commercialisation roadmap
·      (8:14): How the diagnostic tests work and deliver value to patients
·      (9:16): Commercialisation strategy across key regions
·      (11:23): Additional assets in the PIQ pipeline
·      (12:36): What investors can expect over the next 12 months

Note: This interview was recorded on 3 July 2025.

Morning Bell 2 November

Paulina Peters
November 2, 2021

Morning Bell 1 November

Sophia Mavridis
November 1, 2021

Weekly Wrap 29 October

Sophia Mavridis
October 29, 2021

Morning Bell 28 October

Paulina Peters
October 28, 2021

Morning Bell 27 October

Sophia Mavridis
October 27, 2021

Morning Bell 26 October

Paulina Peters
October 26, 2021

Morning Bell 25 October

Sophia Mavridis
October 25, 2021

Weekly Wrap 22 October

Sophia Mavridis
October 22, 2021

Morning Bell 21 October

Paulina Peters
October 21, 2021

Morning Bell 20 October

Jessica Amir
October 20, 2021

Morning Bell 19 October

Jessica Amir
October 19, 2021

Morning Bell 18 October

Jessica Amir
October 18, 2021